Potency of Meropenem-Vaborbactam in Lung Surfactant.

about

Potency of Meropenem-Vaborbactam in Lung Surfactant.

Item

http://www.wikidata.org/entity/Q50077296

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Potency of Meropenem-Vaborbactam in Lung Surfactant.

@en

Potency of Meropenem-Vaborbactam in Lung Surfactant.

@nl

type

Item

label

Potency of Meropenem-Vaborbactam in Lung Surfactant.

@en

Potency of Meropenem-Vaborbactam in Lung Surfactant.

@nl

prefLabel

Potency of Meropenem-Vaborbactam in Lung Surfactant.

@en

Potency of Meropenem-Vaborbactam in Lung Surfactant.

@nl

P1476

Potency of Meropenem-Vaborbactam in Lung Surfactant.

@en

P2093

Debora Rubio-Aparicio

http://www.w3.org/2001/XMLSchema#string

Jeff Loutit

http://www.w3.org/2001/XMLSchema#string

Michael Dudley

http://www.w3.org/2001/XMLSchema#string

Olga Lomovskaya

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases

Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects.

Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae.

Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact.

P31

scholarly article

P356

10.1128/AAC.01702-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29038266

http://www.w3.org/2001/XMLSchema#string

P932

5740353

http://www.w3.org/2001/XMLSchema#string